References
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
- Hashibe M, Brennan P, Chuang S-C, Boccia S, Castellsague X, Chen C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541–50.
- Dayyani F, Etzel CJ, Liu M, Ho C-H, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15.
- Schlumpf M, Fischer C, Naehrig D, Rochlitz C, Buess M. Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality. BMC Cancer 2013;13:610.
- Cheung CHA, Huang C-C, Tsai F-Y, Lee JY-C, Cheng SM, Chang Y-C, et al. Survivin: biology and potential as a therapeutic target in oncology. Onco Targets Ther 2013;6:1453–62.
- Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Embo J 1999;18:5242–51.
- Qi G, Kudo Y, Ando T, Tsunematsu T, Shimizu N, Siriwardena SBSM, et al. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B. Oral Oncol 2010;46:263–70.
- Sun Q, Zheng X, Zhang L, Yu J. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway. Clin Cancer Res 2011;17:2361–72.
- Moon J-H, Shin J-S, Hong S-W, Jung S-A, Hwang I-Y, Kim JH, et al. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer. Oncotarget 2015;6:26895–908.
- Kadletz L, Bigenzahn J, Thurnher D, Stanisz I, Erovic BM, Schneider S, et al. Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma. Head Neck 2016;38:E1918–25.
- Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006;1:2315–9.
- Tolcher A, Bendell JC, Papadopoulos KP, Burris HA, Patnaik A, Fairbrother WJ, et al. A phase i dose escalation study evaluating the safety tolerability and pharmacokinetics of cudc-427, a potent, oral, monovalent iap antagonist, in patients with refractory solid tumors. Clin Cancer Res 2016;22:4567–73.
- Atoyan R, Samson ME, Hantzis B, Ma AW, Ling T, Borek M, et al. Post-treatment changes in levels of tnf family ligands and xiap may predict sensitivity to iap antagonist cudc-427. Presented at the AACR Meeting held at San Diego, CA, USA; 2014.
- Giagkousiklidis S, Vogler M, Westhoff M-A, Kasperczyk H, Debatin K-M, Fulda S. Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res 2005;65:10502–13.
- Fandy TE, Shankar S, Srivastava RK. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer 2008;7:60.
- Kim J, Park J, Choi S, Chi S-G, Mowbray AL, Jo H, et al. X-linked inhibitor of apoptosis protein is an important regulator of vascular endothelial growth factor-dependent bovine aortic endothelial cell survival. Circ Res 2008;102:896–904.
- DiPersio JF, Erba HP, Larson RA, Luger SM, Tallman MS, Brill JM, et al. Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia – results of a phase I dose-escalation study. Clin Lymphoma Myeloma Leuk 2015;15:443–9.
- Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 2010;17:53–64.
- Geisbrecht ER, Montell DJ. A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell 2004;118:111–25.
- Dogan T, Harms GS, Hekman M, Karreman C, Oberoi TK, Alnemri ES, et al. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat Cell Biol 2008;10:1447–55.